Home › Celgene Co. (CELG) Upgraded to Strong-Buy at Vetr Inc.
 

Keywords :   


Celgene Co. (CELG) Upgraded to Strong-Buy at Vetr Inc.

2015-12-31 18:25:53| Biotech - Topix.net

The firm presently has a $133.83 price objective on the biopharmaceutical company's stock. Vetr 's price target points to a potential upside of 10.90% from the company's current price.

Tags: inc upgraded celgene celg

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »